<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Aptos;}
@font-face
	{font-family:"Aptos Display";}
@font-face
	{font-family:"DengXian Light";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"\@DengXian Light";}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-weight:normal;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"DengXian Light";
	color:#0F4761;}
.MsoChpDefault
	{font-family:"Aptos",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU style='word-wrap:break-word'>

<div class=WordSection1>

<h2>2025ADVANCE Describe the pharmacology of methadone.</h2>

<p class=MsoNormal>&nbsp;</p>

<h3>Physicochemical:</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Origin</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>First synthesised
  in Germany… in 1937…</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Presentation</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Oral (tablet,
  liquid)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>IV methadone
  HCl 10mg/mL</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Chemistry</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Synthetic
  diphenylheptanone</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>MW 346g/mol</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>pKa 8.5, 10%
  unionised</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Highly lipid
  soluble (Octanol:Water 115)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Stereochemistry</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Racemic
  mixture</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>R-methadone:
  opioid</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>S-methadone:
  NMDA antagonist, monoamine reuptake inhibitor, &#8593;QTc</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>Pharmacokinetic</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Administration</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>PO</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>IV, IM, SC</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Dosing</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8804;0.1mg/kg
  -&gt; day case</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>0.15-0.25mg/kg
  -&gt; overnight stay</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8805;0.3mg/kg
  -&gt; ICU</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Time course</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Onset: within
  minutes</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Peak: analgesia
  10 mins, resp depression ? 30 mins</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Duration:
  dose-dependent</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-10mg: few
  hours analgesia</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-20mg: 1 day
  analgesia</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-30mg: 3 days
  analgesia</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Absorption</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Oral
  bioavailability 75%: low first pass hepatic metabolism</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Variable time
  to peak effect 1-5 hours</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Distribution</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Highly bound
  to plasma proteins (&#945;1AG,  90%)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Extensively
  distributed (VDss 6L/kg)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Moderately
  quick distribution to tissues (t<sub>1/2&#945;</sub> 6 mins)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Moderately
  quick equilibration with CNS (t<sub>1/2ke0 </sub>8 mins)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Crosses
  placenta. Pregnancy Class C</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Small amounts
  in breast milk (N.B. minimal intake first week of life FML)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Metabolism</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;text-align:justify;line-height:
  normal'><u>Pathways:</u></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Hepatic Phase
  1 N-demethylation by 2B6 &gt; 3A4 &gt; 2C19, 2C9, 2D6</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Major
  metabolite inactive (EDDP -&gt; EMDP)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Minor
  metabolite weakly active (nor-methadol)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Speed:</u></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Longest
  duration of all opioids</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Cl 6mL/kg/min</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>t<sub>1/2&#946;</sub>
  15-60 hours, mean 1 day</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Variability:</u></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Significant 2B6
  polymorphism</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Reduced
  function alleles common worldwide</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Oceania (60%)
  &gt; Africa (40%) &gt; Europe (30%) &gt; Asia (20%)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Affects
  S-methadone &gt;&gt; R-methadone</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Slow
  phenotype -&gt; &#8593;S-methadone -&gt; &#8593;QTc with repeat dosing</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Minimal
  effect on duration of opioid activity</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Excretion</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Parent -&gt;
  Urine (up to 20-40%)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8593; if
  &#8595;pH</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8593; if
  renal failure -&gt; &#8593;duration of single dose; &#8593;accumulation if
  repeat dose</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Metabolites
  -&gt; bile, urine</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>Pharmacodynamic</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Receptor
  effects</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Full &#956;
  opioid agonist</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>NMDA
  antagonist (contribution unknown, likely less than ketamine)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>NAd and 5HT
  reuptake inhibitor</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Thresholds</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>(see graph)</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Severe Resp
  Depression: &gt;100ng/mL</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Strong
  Analgesia: &gt;60ng/mL</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Some
  Analgesia: &gt;30ng/mL</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Uses</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Opioid addiction</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Opioid
  withdrawal</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Acute &amp;
  chronic pain</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Somatic &amp;
  visceral &amp; neuropathic pain</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Evidence base
  across many surgical specialties</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Benefits</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8595;Opioid
  side effects (cf. pure opioids at equi-analgesic doses)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8595;Opioid
  use (up to 3/12 post-op)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&#8595;Pain
  scores (up to 3/12 post-op)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>The above
  could reduce the risk of long-term use and addiction</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Respiratory
  depression</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Especially
  with benzodiazapines, gabapentinoids</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Especially if
  sleep-disordered breathing</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Partial
  reversal of effect with naloxone</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Highest risk
  30-45 mins (cf. intrathecal morphine 6 hours)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Serotonin
  syndrome</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Mostly with
  high doses</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Mostly if
  combined with other serotonergic drugs</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>MAOi (14 days
  offset), tramadol, pethidine, TCA, SSRI*</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>(*Methadone +
  SSRI is common and appears safe)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Torsades de
  Pointes</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Inhibits
  myocardial K+ (I<sub>Kr</sub>) channels -&gt; &#8593;QTc <i>and</i>
  &#8593;risk TdP</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Issue if a)
  congenital long QT b) Other Class 3 antiarrhythmic b) &#8595;K+, &#8595;Mg</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Usually with repeated
  high dose (&gt;100mg/day)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Could be
  mimicked with a big IV push</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>PK &amp; PD:</h3>

<p class=MsoNormal><img width=599 height=411 id="Picture 2"
src="2025ADVANCE_methadone_files/image001.jpg"></p>

<h3>User’s Guide:</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Dosing</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Day case:
  5-10mg (e.g. elective lap chole)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Overnight
  stay: 10-20mg (e.g. joint replacement)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>ICU major: 20-30mg
  (e.g. upper midline laparotomy)</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Timing</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Give a bit at
  a time, e.g. 2-3mg q2 mins</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Give most of
  it early: anaesthetic room vs induction vs pre-incision</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Give a small top
  up at end of case if needed</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Titrate
  against pupil size, RR, PaCO2</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Adjuvants</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Ketamine: <b>Yes</b>.
  Significant extra benefit. Give as you normally would.</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Gabapentinoids:
  <b>No. </b>Associated with opioid toxicity.</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Benzos: <b>Careful</b>.
  Avoid if short procedure. Avoid if day case. Avoid if sleep-disordered
  breathing. <i>BUT s</i>mall dose ok when lining up for major procedure. Opioids
  aren’t anxiolytic, come at me.</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Pure opioids:
  <b>Careful</b>. Suggest fentanyl or alfentanil at induction, and standard
  protocol in PACU. Definitely avoid intrathecal morphine.</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Anaesthetic</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Strategies
  for waking a comfortable patient after a long procedure</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-Processed
  EEG monitoring to facilitate titration</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-Sevoflurane
  -&gt; propofol +/- remifentanil (mid-procedure switch)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>-Sevoflurane
  -&gt; desflurane (mid-procedure switch, if it’s in stock)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>(Sevoflurane’s
  90% decrement time climbs steeply after 2 hours)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
